183 related articles for article (PubMed ID: 15994737)
21. Efficacy of olanzapine: an overview of pivotal clinical trials.
Beasley CM; Tollefson GD; Tran PV
J Clin Psychiatry; 1997; 58 Suppl 10():7-12. PubMed ID: 9265910
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of antipsychotic drugs.
Gupta S
Am J Psychiatry; 2003 Mar; 160(3):591; author reply 592-3. PubMed ID: 12611855
[No Abstract] [Full Text] [Related]
23. Pharmacological profile of risperidone.
Ereshefsky L; Lacombe S
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S80-8. PubMed ID: 7504573
[TBL] [Abstract][Full Text] [Related]
24. Comparative effectiveness of antipsychotic drugs.
Osser DN; Akhter A
Am J Psychiatry; 2003 Mar; 160(3):590; author reply 592-3. PubMed ID: 12611853
[No Abstract] [Full Text] [Related]
25. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
26. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
27. Olanzapine monotherapy for late-onset vocal tics in a schizophrenic patient.
Cheng WJ; Liu HC; Huang MC
Psychiatry Clin Neurosci; 2007 Dec; 61(6):700-1. PubMed ID: 18081638
[No Abstract] [Full Text] [Related]
28. Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat.
Naiker DV; Catts SV; Catts VS; Bedi KS; Bryan-Lluka LJ
Eur J Pharmacol; 2006 Jul; 540(1-3):87-90. PubMed ID: 16730699
[TBL] [Abstract][Full Text] [Related]
29. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.
Keefe RS; Young CA; Rock SL; Purdon SE; Gold JM; Breier A;
Schizophr Res; 2006 Jan; 81(1):1-15. PubMed ID: 16202565
[TBL] [Abstract][Full Text] [Related]
30. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
Tollefson GD; Sanger TM
Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
[TBL] [Abstract][Full Text] [Related]
31. Dosing the antipsychotic medication olanzapine.
Nemeroff CB
J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
[TBL] [Abstract][Full Text] [Related]
32. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
Caforio G; Di Giorgio A; Rampino A; Rizzo M; Romano R; Taurisano P; Fazio L; De Simeis G; Ursini G; Blasi G; Nardini M; Mancini M; Bertolino A
J Clin Psychopharmacol; 2013 Dec; 33(6):810-2. PubMed ID: 24113675
[No Abstract] [Full Text] [Related]
33. Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients.
Vallabhajosula S; Hirschowitz J; Machac J
J Nucl Med; 1997 Feb; 38(2):203-7. PubMed ID: 9025736
[TBL] [Abstract][Full Text] [Related]
34. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
Olsen CK; Brennum LT; Kreilgaard M
Eur J Pharmacol; 2008 Apr; 584(2-3):318-27. PubMed ID: 18325493
[TBL] [Abstract][Full Text] [Related]
35. Olanzapine vs haloperidol for treatment of schizophrenia.
Kunz M
JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996768
[No Abstract] [Full Text] [Related]
36. Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol.
Sayers SL; Campbell EC; Kondrich J; Mann SC; Cornish J; O'Brien C; Caroff SN
J Nerv Ment Dis; 2005 Jun; 193(6):379-86. PubMed ID: 15920378
[TBL] [Abstract][Full Text] [Related]
37. Olanzapine vs haloperidol for treatment of schizophrenia.
Volavka J; Citrome L
JAMA; 2004 Mar; 291(9):1064; author reply 1065-6. PubMed ID: 14996765
[No Abstract] [Full Text] [Related]
38. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
[TBL] [Abstract][Full Text] [Related]
39. Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.
Apiquian R; Fresán A; Herrera K; Ulloa RE; Lóyzaga C; de la Fuente-Sandoval C; Gutiérrez D; Nicolini H
Int J Neuropsychopharmacol; 2003 Dec; 6(4):403-8. PubMed ID: 14604455
[TBL] [Abstract][Full Text] [Related]
40. Olanzapine vs haloperidol for treatment of schizophrenia.
Glazer WM
JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]